Tag: street

DALLAS, June 24, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced the pricing of an underwritten public offering of 32,500,001 shares of its common stock at a price to the public of $6.00 per share and, in lieu of common stock to certain investors that so choose, pre-funded warrants to purchase 833,333 shares of its common stock at an offering price of $5.999 per pre-funded warrant, in each case before underwriting discounts and commissions. All of the securities are being offered by Taysha. In addition, Taysha has granted the underwriters a 30-day option to purchase up to an additional 5,000,000 shares of common stock at the public offering price, less underwriting discounts and commissions. The gross proceeds from the offering to Taysha are expected to be approximately $200.0 million, before deducting underwriting discounts and commissions and other offering expenses, excluding any exercise of the underwriters’ option to purchase additional shares. The offering is expected to close on or about June 26, 2026, subject to customary closing conditions.

TORONTO, June 24, 2026 /CNW/ - Jamieson Wellness Inc. ("Jamieson" or the "Company") (TSX: JWEL) acknowledges a recent media report regarding a potential sale...

RALEIGH, N.C., June 24, 2026 /PRNewswire/ -- Cardinal Infrastructure Group, Inc. (the "Company" or "Cardinal") (Nasdaq: CDNL) today announced the pricing of an upsized...

Partnership enhances fan experiences, expands access, and enables seamless, global participation—online and on the groundLOS ANGELES, June 24, 2026 /PRNewswire/ -- The Evolution Championship Series...

LONDON, June 24, 2026 /PRNewswire/ -- The global biochar market is expected to be valued at US$ 910.4 million in 2026 and projected to...

LONDON, June 24, 2026 /PRNewswire/ -- The global biochar market is expected to be valued at US$ 910.4 million in 2026 and projected to...

Closed transaction provided $15 million in New Markets Tax Credit financing for the construction of a new K-12 public charter school in the Bronx.

Closed transaction provided $15 million in New Markets Tax Credit financing for the construction of a new K-12 public charter school in the Bronx.

TOKYO, June 24, 2026 (GLOBE NEWSWIRE) -- Lead Real Estate Co., Ltd. (Nasdaq: LRE) (“LRE” or the “Company”), a Japanese real estate developer of luxury residential properties and operator of the ENT TERRACE brand of extended-stay hotels, has opened ENT TERRACE GAKUGEIDAIGAKU PREMIUM, located in Takaban, Meguro, Tokyo. The property completed construction on March 31, 2026, and scheduled to open at the end of this month.

BURLINGTON, ON, June 23, 2026 /CNW/ - SIR Royalty Income Fund (TSX: SRV.UN) (the "Fund") today announced that SIR Corp. ("SIR" or the "Company"),...

KELOWNA, BC, June 23, 2026 /CNW/ - People in the Kelowna Regional Transit System will soon be able to get to their destinations aboard an...

GATINEAU, QC, June 23, 2026 /CNW/ - Public Services and Procurement Canada (PSPC) wishes to advise motorists that there will be a full closure...

MOORE, Okla., June 23, 2026 /PRNewswire/ -- Today, the Oklahoma Department of Commerce and the Cleveland County Economic Development Coalition announced that announced that...

Sky Equity Group Celebrates Major Construction Milestone at Luxury CondominiumNEW YORK, June 23, 2026 /PRNewswire/ -- Sky Equity Group, the New York City-based real estate...